# The Efficacy and Safety of SeQuent® Please in the Treatment of Small Vessel Disease (SVD) Patient

> **NCT03625830** · NA · UNKNOWN · sponsor: **B. Braun Medical International Trading Company Ltd.** · enrollment: 270 (estimated)

## Conditions studied

- Small Vessel Disease

## Interventions

- **DEVICE:** Paclitaxel-eluting PTCA-Balloon Catheter(SeQuent® Please)
- **DEVICE:** rapid exchange PTCA -Balloon Catheter (SeQuent® Neo)

## Key facts

- **NCT ID:** NCT03625830
- **Lead sponsor:** B. Braun Medical International Trading Company Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-18
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625830, "The Efficacy and Safety of SeQuent® Please in the Treatment of Small Vessel Disease (SVD) Patient". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03625830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*